Accelmed Partners — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Guy Jordan(Director)Floyd Loop, M.D.(Director)Josh DeFonzo(Executive Officer)
Board seatUri Geiger· per SEC Form D
Co-investorsCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupDe Novo VenturesFOUNDATION MEDICAL PARTNERS+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.